The end targets of these pathways, including cytokines (IL1A/B, IL6, IL8, IL18) and genes related to cell proliferation (JUN, SRF), were upregulated, suggesting that the activation of these TLRs leads to tumor growth. This evidence concerns the gene JUN and neoplasm.